which companies make glp 1 drugs 2025’s Breakthrough GLP-1 Obesity Treatments: Top & Innovations 2 Companies Poised to Capitalize

If you do not experience an immediate reduction in your appetite, do not feel discouraged or assume the treatment is failing

Li J, Liu X, Hu L, et al

Finally, GLP-1 RAs may have a role in treating nonalcoholic steatohepatitis through lowering hepatic inflammation, steatosis and fibrosis, although the mechanistic basis for this is yet to be determined [128]

Among them, 2 million people had type 1 diabetes, with 304,000 being children and adolescents

dose-dependent response across 3, 6, and 9 mg arms Phase 3 T2D : HbA1c reductions up to 2.15% versus placebo in Chinese population trials Phase 1b/2 data : Earlier dose-finding studies establishing the efficacy and tolerability profile Global development : Ongoing clinical trials outside China, but no FDA approval or submission as of early 2026 Limitation : Primary clinical data from Chinese population